4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001415889-24-026138
INTERIM PRESIDENT AND CEO gave up 2,721 shares (to pay taxes)
- INTERIM PRESIDENT AND CEO acquired 9,467 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Neal INTERIM PRESIDENT AND CEO | 2024-11-01 | Option exercise | +9,467 | 1,379,109 | D | ||
| Walker Neal INTERIM PRESIDENT AND CEO | 2024-11-01 | Shares withheld for taxes | −2,721 | $2.09 | $5,687 | 1,376,388 | D |
| Derivatives | |||||||
| Walker Neal INTERIM PRESIDENT AND CEO | 2024-11-01 | Option exercise · Restricted Stock Units | −9,467 | 56,800 | D | ||
Loading xslF345X05/form4-11052024_041101.xml…